NasdaqGM:SEPNPharmaceuticals
Septerna (SEPN) Q4 Loss Despite Revenue Surge Reinforces Bearish Profitability Narrative
Septerna (SEPN) just closed out FY 2025 with Q4 revenue of US$24.1 million, a basic EPS loss of US$0.24 and quarterly net income excluding extra items showing a loss of US$10.7 million, while trailing twelve month revenue reached US$46.0 million and EPS was a loss of US$1.10. Over the past few quarters, the company has seen revenue move from US$0.21 million in Q4 FY 2024 to US$24.1 million in Q4 FY 2025. Basic EPS ranged from a loss of US$0.64 in Q4 FY 2024 to a profit of US$0.18 in Q3 FY...